Global (United States, European Union and China) Microarray Scanner

Microarray Scanner Comprehensive Study by Type (Charge-Coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, Fluorescence Microarray Scanners, Microarray Laser Scanners, Microarray Plate Scanners, Others), Application (Drug Discovery, Gene Expression, Mutation Detection, SNP analysis, Others), By End User (Academic Institutes, Diagnostic Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes) Players and Region - Global Market Outlook to 2030

Microarray Scanner Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Microarray Scanner Market Scope
Microarray Scanners are systems used to gauge the fluorescent spaces of a DNA microarray to uncover data about the concurrent action of thousands of genes. Microarray scanners are broadly utilized in practical science, cellomics, quality articulation, and medication revelation research. Microarray Scanner, significant elements are sensitivity, goal, filter region, speed of the scan, and convenience. Microarray Scanners for the most part have red, green, and blue excitation frequencies and a wide decision of up to 8 emanation channels that empower imaging of a broad assortment of fluorophores (for example Cy3, Cy5, FITC, and Texas Red). Microarray Scanner framework with self-adjust that constantly acclimates to keep highlights while scanning, confocal optics that consider the sensitive location of low-abundance targets, or computerized multi fluorescence checking that permits multiplexing.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAgilent Technologies (United States), Berthold Technologies GmbH & Co. KG. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (General Electric Company) (United States), Illumina, Inc. (United States), Innopsys Inc. (United States), Molecular Devices, LLC. (Danaher Corporation) (United States), PerkinElmer, Inc. (United States), Thermo Fisher Scientific (United States) and Integrated Gulf Biosystems (Abu Dhabi)
CAGR6.6%


The Microarray Scanner Market is engaged with different small and giant organizations. Most of the organizations in the microarray scanners market are entering into strategic partnerships to increase the availability of high technology solutions about innovative microarray platforms. Moreover, these companies are involved in the expansion activities of their business operations in developing countries to avail a competitive advantage over other players. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Microarray Scanner market throughout the predicted period.

Agilent Technologies (United States), Berthold Technologies GmbH & Co. KG. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (General Electric Company) (United States), Illumina, Inc. (United States), Innopsys Inc. (United States), Molecular Devices, LLC. (Danaher Corporation) (United States), PerkinElmer, Inc. (United States), Thermo Fisher Scientific (United States) and Integrated Gulf Biosystems (Abu Dhabi) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Arrayit (United States), Bioautomation Corporation (United States), EUROIMMUN (Germany), Bio-Rad Laboratories, Inc. (United States) and Molecular Devices (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Microarray Scanner market by Type , by Application (Drug Discovery, Gene Expression, Mutation Detection, SNP analysis and Others) and Region with country level break-up.

On the basis of geography, the market of Microarray Scanner has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In January 2021, Exact Therapeutics, a clinical-stage precision medicine company, announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies. This collaboration with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound, developing an innovative ultrasound probe to enable the effective deployment of the ACT therapeutic amplification platform.
In September 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency, and profitability with an industry-leading two-day turnaround time. Providing insights on chromosomal variants for a wide range of prenatal, postnatal, and oncology research applications, the Applied Biosystems™ CytoScan™
The Food and Drug Administration (FDA), the regulatory authority of the United States encourages the development of new technologies regarding microarrays which may improve and streamline assessments of safety and the effectiveness of medical products for the benefit of public health.

Influencing Trend:
Increase in drug discovery activities in health care and Growing research and development for technological advancements, and wide applications of microarray analysis

Market Growth Drivers:
Increase in the population with infectious diseases such as COVID-19 and Increasing focus in gene expression and drug discovery to address the different infection spread

Challenges:
Stringent regulatory authorities of different countries

Restraints:
The high initial cost of the owning microarray scanner and Lack of skilled personnel’s to operate and handle the concerned activity

Opportunities:
Development of advanced technology which is prominent in delivering the required result and Increase in research activities and develop medical infrastructure in developing countries

Key Target Audience
Industry Associations, Government Regulatory Authorities, Health and Medical Equipment Suppliers, Health and Medical Equipment Manufacturer, Bio-Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Charge-Coupled Devices Microarray Scanners
  • Colorimetric Microarray Scanners
  • Fluorescence Microarray Scanners
  • Microarray Laser Scanners
  • Microarray Plate Scanners
  • Others
By Application
  • Drug Discovery
  • Gene Expression
  • Mutation Detection
  • SNP analysis
  • Others
By By End User
  • Academic Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the population with infectious diseases such as COVID-19
      • 3.2.2. Increasing focus in gene expression and drug discovery to address the different infection spread
    • 3.3. Market Challenges
      • 3.3.1. Stringent regulatory authorities of different countries
    • 3.4. Market Trends
      • 3.4.1. Increase in drug discovery activities in health care
      • 3.4.2. Growing research and development for technological advancements, and wide applications of microarray analysis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Microarray Scanner, by Type, Application, By End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Microarray Scanner (Value)
      • 5.2.1. Global Microarray Scanner by: Type (Value)
        • 5.2.1.1. Charge-Coupled Devices Microarray Scanners
        • 5.2.1.2. Colorimetric Microarray Scanners
        • 5.2.1.3. Fluorescence Microarray Scanners
        • 5.2.1.4. Microarray Laser Scanners
        • 5.2.1.5. Microarray Plate Scanners
        • 5.2.1.6. Others
      • 5.2.2. Global Microarray Scanner by: Application (Value)
        • 5.2.2.1. Drug Discovery
        • 5.2.2.2. Gene Expression
        • 5.2.2.3. Mutation Detection
        • 5.2.2.4. SNP analysis
        • 5.2.2.5. Others
      • 5.2.3. Global Microarray Scanner by: By End User (Value)
        • 5.2.3.1. Academic Institutes
        • 5.2.3.2. Diagnostic Laboratories
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Pharmaceutical & Biotechnology Companies
        • 5.2.3.5. Research Institutes
      • 5.2.4. Global Microarray Scanner Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Microarray Scanner: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Berthold Technologies GmbH & Co. KG. (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (General Electric Company) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Illumina, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Innopsys Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Molecular Devices, LLC. (Danaher Corporation) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PerkinElmer, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Integrated Gulf Biosystems (Abu Dhabi)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Microarray Scanner Sale, by Type, Application, By End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Microarray Scanner (Value)
      • 7.2.1. Global Microarray Scanner by: Type (Value)
        • 7.2.1.1. Charge-Coupled Devices Microarray Scanners
        • 7.2.1.2. Colorimetric Microarray Scanners
        • 7.2.1.3. Fluorescence Microarray Scanners
        • 7.2.1.4. Microarray Laser Scanners
        • 7.2.1.5. Microarray Plate Scanners
        • 7.2.1.6. Others
      • 7.2.2. Global Microarray Scanner by: Application (Value)
        • 7.2.2.1. Drug Discovery
        • 7.2.2.2. Gene Expression
        • 7.2.2.3. Mutation Detection
        • 7.2.2.4. SNP analysis
        • 7.2.2.5. Others
      • 7.2.3. Global Microarray Scanner by: By End User (Value)
        • 7.2.3.1. Academic Institutes
        • 7.2.3.2. Diagnostic Laboratories
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Pharmaceutical & Biotechnology Companies
        • 7.2.3.5. Research Institutes
      • 7.2.4. Global Microarray Scanner Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Microarray Scanner: by Type(USD Million)
  • Table 2. Microarray Scanner Charge-Coupled Devices Microarray Scanners , by Region USD Million (2018-2023)
  • Table 3. Microarray Scanner Colorimetric Microarray Scanners , by Region USD Million (2018-2023)
  • Table 4. Microarray Scanner Fluorescence Microarray Scanners , by Region USD Million (2018-2023)
  • Table 5. Microarray Scanner Microarray Laser Scanners , by Region USD Million (2018-2023)
  • Table 6. Microarray Scanner Microarray Plate Scanners , by Region USD Million (2018-2023)
  • Table 7. Microarray Scanner Others , by Region USD Million (2018-2023)
  • Table 8. Microarray Scanner: by Application(USD Million)
  • Table 9. Microarray Scanner Drug Discovery , by Region USD Million (2018-2023)
  • Table 10. Microarray Scanner Gene Expression , by Region USD Million (2018-2023)
  • Table 11. Microarray Scanner Mutation Detection , by Region USD Million (2018-2023)
  • Table 12. Microarray Scanner SNP analysis , by Region USD Million (2018-2023)
  • Table 13. Microarray Scanner Others , by Region USD Million (2018-2023)
  • Table 14. Microarray Scanner: by By End User(USD Million)
  • Table 15. Microarray Scanner Academic Institutes , by Region USD Million (2018-2023)
  • Table 16. Microarray Scanner Diagnostic Laboratories , by Region USD Million (2018-2023)
  • Table 17. Microarray Scanner Hospitals , by Region USD Million (2018-2023)
  • Table 18. Microarray Scanner Pharmaceutical & Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 19. Microarray Scanner Research Institutes , by Region USD Million (2018-2023)
  • Table 20. South America Microarray Scanner, by Country USD Million (2018-2023)
  • Table 21. South America Microarray Scanner, by Type USD Million (2018-2023)
  • Table 22. South America Microarray Scanner, by Application USD Million (2018-2023)
  • Table 23. South America Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 24. Brazil Microarray Scanner, by Type USD Million (2018-2023)
  • Table 25. Brazil Microarray Scanner, by Application USD Million (2018-2023)
  • Table 26. Brazil Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 27. Argentina Microarray Scanner, by Type USD Million (2018-2023)
  • Table 28. Argentina Microarray Scanner, by Application USD Million (2018-2023)
  • Table 29. Argentina Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 30. Rest of South America Microarray Scanner, by Type USD Million (2018-2023)
  • Table 31. Rest of South America Microarray Scanner, by Application USD Million (2018-2023)
  • Table 32. Rest of South America Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 33. Asia Pacific Microarray Scanner, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Microarray Scanner, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific Microarray Scanner, by Application USD Million (2018-2023)
  • Table 36. Asia Pacific Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 37. China Microarray Scanner, by Type USD Million (2018-2023)
  • Table 38. China Microarray Scanner, by Application USD Million (2018-2023)
  • Table 39. China Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 40. Japan Microarray Scanner, by Type USD Million (2018-2023)
  • Table 41. Japan Microarray Scanner, by Application USD Million (2018-2023)
  • Table 42. Japan Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 43. India Microarray Scanner, by Type USD Million (2018-2023)
  • Table 44. India Microarray Scanner, by Application USD Million (2018-2023)
  • Table 45. India Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 46. South Korea Microarray Scanner, by Type USD Million (2018-2023)
  • Table 47. South Korea Microarray Scanner, by Application USD Million (2018-2023)
  • Table 48. South Korea Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 49. Taiwan Microarray Scanner, by Type USD Million (2018-2023)
  • Table 50. Taiwan Microarray Scanner, by Application USD Million (2018-2023)
  • Table 51. Taiwan Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 52. Australia Microarray Scanner, by Type USD Million (2018-2023)
  • Table 53. Australia Microarray Scanner, by Application USD Million (2018-2023)
  • Table 54. Australia Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Microarray Scanner, by Type USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Microarray Scanner, by Application USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 58. Europe Microarray Scanner, by Country USD Million (2018-2023)
  • Table 59. Europe Microarray Scanner, by Type USD Million (2018-2023)
  • Table 60. Europe Microarray Scanner, by Application USD Million (2018-2023)
  • Table 61. Europe Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 62. Germany Microarray Scanner, by Type USD Million (2018-2023)
  • Table 63. Germany Microarray Scanner, by Application USD Million (2018-2023)
  • Table 64. Germany Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 65. France Microarray Scanner, by Type USD Million (2018-2023)
  • Table 66. France Microarray Scanner, by Application USD Million (2018-2023)
  • Table 67. France Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 68. Italy Microarray Scanner, by Type USD Million (2018-2023)
  • Table 69. Italy Microarray Scanner, by Application USD Million (2018-2023)
  • Table 70. Italy Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 71. United Kingdom Microarray Scanner, by Type USD Million (2018-2023)
  • Table 72. United Kingdom Microarray Scanner, by Application USD Million (2018-2023)
  • Table 73. United Kingdom Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 74. Netherlands Microarray Scanner, by Type USD Million (2018-2023)
  • Table 75. Netherlands Microarray Scanner, by Application USD Million (2018-2023)
  • Table 76. Netherlands Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 77. Rest of Europe Microarray Scanner, by Type USD Million (2018-2023)
  • Table 78. Rest of Europe Microarray Scanner, by Application USD Million (2018-2023)
  • Table 79. Rest of Europe Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 80. MEA Microarray Scanner, by Country USD Million (2018-2023)
  • Table 81. MEA Microarray Scanner, by Type USD Million (2018-2023)
  • Table 82. MEA Microarray Scanner, by Application USD Million (2018-2023)
  • Table 83. MEA Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 84. Middle East Microarray Scanner, by Type USD Million (2018-2023)
  • Table 85. Middle East Microarray Scanner, by Application USD Million (2018-2023)
  • Table 86. Middle East Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 87. Africa Microarray Scanner, by Type USD Million (2018-2023)
  • Table 88. Africa Microarray Scanner, by Application USD Million (2018-2023)
  • Table 89. Africa Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 90. North America Microarray Scanner, by Country USD Million (2018-2023)
  • Table 91. North America Microarray Scanner, by Type USD Million (2018-2023)
  • Table 92. North America Microarray Scanner, by Application USD Million (2018-2023)
  • Table 93. North America Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 94. United States Microarray Scanner, by Type USD Million (2018-2023)
  • Table 95. United States Microarray Scanner, by Application USD Million (2018-2023)
  • Table 96. United States Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 97. Canada Microarray Scanner, by Type USD Million (2018-2023)
  • Table 98. Canada Microarray Scanner, by Application USD Million (2018-2023)
  • Table 99. Canada Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 100. Mexico Microarray Scanner, by Type USD Million (2018-2023)
  • Table 101. Mexico Microarray Scanner, by Application USD Million (2018-2023)
  • Table 102. Mexico Microarray Scanner, by By End User USD Million (2018-2023)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Microarray Scanner: by Type(USD Million)
  • Table 114. Microarray Scanner Charge-Coupled Devices Microarray Scanners , by Region USD Million (2025-2030)
  • Table 115. Microarray Scanner Colorimetric Microarray Scanners , by Region USD Million (2025-2030)
  • Table 116. Microarray Scanner Fluorescence Microarray Scanners , by Region USD Million (2025-2030)
  • Table 117. Microarray Scanner Microarray Laser Scanners , by Region USD Million (2025-2030)
  • Table 118. Microarray Scanner Microarray Plate Scanners , by Region USD Million (2025-2030)
  • Table 119. Microarray Scanner Others , by Region USD Million (2025-2030)
  • Table 120. Microarray Scanner: by Application(USD Million)
  • Table 121. Microarray Scanner Drug Discovery , by Region USD Million (2025-2030)
  • Table 122. Microarray Scanner Gene Expression , by Region USD Million (2025-2030)
  • Table 123. Microarray Scanner Mutation Detection , by Region USD Million (2025-2030)
  • Table 124. Microarray Scanner SNP analysis , by Region USD Million (2025-2030)
  • Table 125. Microarray Scanner Others , by Region USD Million (2025-2030)
  • Table 126. Microarray Scanner: by By End User(USD Million)
  • Table 127. Microarray Scanner Academic Institutes , by Region USD Million (2025-2030)
  • Table 128. Microarray Scanner Diagnostic Laboratories , by Region USD Million (2025-2030)
  • Table 129. Microarray Scanner Hospitals , by Region USD Million (2025-2030)
  • Table 130. Microarray Scanner Pharmaceutical & Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 131. Microarray Scanner Research Institutes , by Region USD Million (2025-2030)
  • Table 132. South America Microarray Scanner, by Country USD Million (2025-2030)
  • Table 133. South America Microarray Scanner, by Type USD Million (2025-2030)
  • Table 134. South America Microarray Scanner, by Application USD Million (2025-2030)
  • Table 135. South America Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 136. Brazil Microarray Scanner, by Type USD Million (2025-2030)
  • Table 137. Brazil Microarray Scanner, by Application USD Million (2025-2030)
  • Table 138. Brazil Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 139. Argentina Microarray Scanner, by Type USD Million (2025-2030)
  • Table 140. Argentina Microarray Scanner, by Application USD Million (2025-2030)
  • Table 141. Argentina Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 142. Rest of South America Microarray Scanner, by Type USD Million (2025-2030)
  • Table 143. Rest of South America Microarray Scanner, by Application USD Million (2025-2030)
  • Table 144. Rest of South America Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 145. Asia Pacific Microarray Scanner, by Country USD Million (2025-2030)
  • Table 146. Asia Pacific Microarray Scanner, by Type USD Million (2025-2030)
  • Table 147. Asia Pacific Microarray Scanner, by Application USD Million (2025-2030)
  • Table 148. Asia Pacific Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 149. China Microarray Scanner, by Type USD Million (2025-2030)
  • Table 150. China Microarray Scanner, by Application USD Million (2025-2030)
  • Table 151. China Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 152. Japan Microarray Scanner, by Type USD Million (2025-2030)
  • Table 153. Japan Microarray Scanner, by Application USD Million (2025-2030)
  • Table 154. Japan Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 155. India Microarray Scanner, by Type USD Million (2025-2030)
  • Table 156. India Microarray Scanner, by Application USD Million (2025-2030)
  • Table 157. India Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 158. South Korea Microarray Scanner, by Type USD Million (2025-2030)
  • Table 159. South Korea Microarray Scanner, by Application USD Million (2025-2030)
  • Table 160. South Korea Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 161. Taiwan Microarray Scanner, by Type USD Million (2025-2030)
  • Table 162. Taiwan Microarray Scanner, by Application USD Million (2025-2030)
  • Table 163. Taiwan Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 164. Australia Microarray Scanner, by Type USD Million (2025-2030)
  • Table 165. Australia Microarray Scanner, by Application USD Million (2025-2030)
  • Table 166. Australia Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 167. Rest of Asia-Pacific Microarray Scanner, by Type USD Million (2025-2030)
  • Table 168. Rest of Asia-Pacific Microarray Scanner, by Application USD Million (2025-2030)
  • Table 169. Rest of Asia-Pacific Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 170. Europe Microarray Scanner, by Country USD Million (2025-2030)
  • Table 171. Europe Microarray Scanner, by Type USD Million (2025-2030)
  • Table 172. Europe Microarray Scanner, by Application USD Million (2025-2030)
  • Table 173. Europe Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 174. Germany Microarray Scanner, by Type USD Million (2025-2030)
  • Table 175. Germany Microarray Scanner, by Application USD Million (2025-2030)
  • Table 176. Germany Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 177. France Microarray Scanner, by Type USD Million (2025-2030)
  • Table 178. France Microarray Scanner, by Application USD Million (2025-2030)
  • Table 179. France Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 180. Italy Microarray Scanner, by Type USD Million (2025-2030)
  • Table 181. Italy Microarray Scanner, by Application USD Million (2025-2030)
  • Table 182. Italy Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 183. United Kingdom Microarray Scanner, by Type USD Million (2025-2030)
  • Table 184. United Kingdom Microarray Scanner, by Application USD Million (2025-2030)
  • Table 185. United Kingdom Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 186. Netherlands Microarray Scanner, by Type USD Million (2025-2030)
  • Table 187. Netherlands Microarray Scanner, by Application USD Million (2025-2030)
  • Table 188. Netherlands Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 189. Rest of Europe Microarray Scanner, by Type USD Million (2025-2030)
  • Table 190. Rest of Europe Microarray Scanner, by Application USD Million (2025-2030)
  • Table 191. Rest of Europe Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 192. MEA Microarray Scanner, by Country USD Million (2025-2030)
  • Table 193. MEA Microarray Scanner, by Type USD Million (2025-2030)
  • Table 194. MEA Microarray Scanner, by Application USD Million (2025-2030)
  • Table 195. MEA Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 196. Middle East Microarray Scanner, by Type USD Million (2025-2030)
  • Table 197. Middle East Microarray Scanner, by Application USD Million (2025-2030)
  • Table 198. Middle East Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 199. Africa Microarray Scanner, by Type USD Million (2025-2030)
  • Table 200. Africa Microarray Scanner, by Application USD Million (2025-2030)
  • Table 201. Africa Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 202. North America Microarray Scanner, by Country USD Million (2025-2030)
  • Table 203. North America Microarray Scanner, by Type USD Million (2025-2030)
  • Table 204. North America Microarray Scanner, by Application USD Million (2025-2030)
  • Table 205. North America Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 206. United States Microarray Scanner, by Type USD Million (2025-2030)
  • Table 207. United States Microarray Scanner, by Application USD Million (2025-2030)
  • Table 208. United States Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 209. Canada Microarray Scanner, by Type USD Million (2025-2030)
  • Table 210. Canada Microarray Scanner, by Application USD Million (2025-2030)
  • Table 211. Canada Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 212. Mexico Microarray Scanner, by Type USD Million (2025-2030)
  • Table 213. Mexico Microarray Scanner, by Application USD Million (2025-2030)
  • Table 214. Mexico Microarray Scanner, by By End User USD Million (2025-2030)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Microarray Scanner: by Type USD Million (2018-2023)
  • Figure 5. Global Microarray Scanner: by Application USD Million (2018-2023)
  • Figure 6. Global Microarray Scanner: by By End User USD Million (2018-2023)
  • Figure 7. South America Microarray Scanner Share (%), by Country
  • Figure 8. Asia Pacific Microarray Scanner Share (%), by Country
  • Figure 9. Europe Microarray Scanner Share (%), by Country
  • Figure 10. MEA Microarray Scanner Share (%), by Country
  • Figure 11. North America Microarray Scanner Share (%), by Country
  • Figure 12. Global Microarray Scanner share by Players 2023 (%)
  • Figure 13. Global Microarray Scanner share by Players (Top 3) 2023(%)
  • Figure 14. Global Microarray Scanner share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 17. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 18. Berthold Technologies GmbH & Co. KG. (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Berthold Technologies GmbH & Co. KG. (Germany) Revenue: by Geography 2023
  • Figure 20. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2023
  • Figure 22. GE Healthcare (General Electric Company) (United States) Revenue, Net Income and Gross profit
  • Figure 23. GE Healthcare (General Electric Company) (United States) Revenue: by Geography 2023
  • Figure 24. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Illumina, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Innopsys Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Innopsys Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Molecular Devices, LLC. (Danaher Corporation) (United States) Revenue, Net Income and Gross profit
  • Figure 29. Molecular Devices, LLC. (Danaher Corporation) (United States) Revenue: by Geography 2023
  • Figure 30. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. PerkinElmer, Inc. (United States) Revenue: by Geography 2023
  • Figure 32. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 33. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 34. Integrated Gulf Biosystems (Abu Dhabi) Revenue, Net Income and Gross profit
  • Figure 35. Integrated Gulf Biosystems (Abu Dhabi) Revenue: by Geography 2023
  • Figure 36. Global Microarray Scanner: by Type USD Million (2025-2030)
  • Figure 37. Global Microarray Scanner: by Application USD Million (2025-2030)
  • Figure 38. Global Microarray Scanner: by By End User USD Million (2025-2030)
  • Figure 39. South America Microarray Scanner Share (%), by Country
  • Figure 40. Asia Pacific Microarray Scanner Share (%), by Country
  • Figure 41. Europe Microarray Scanner Share (%), by Country
  • Figure 42. MEA Microarray Scanner Share (%), by Country
  • Figure 43. North America Microarray Scanner Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Agilent Technologies (United States)
  • Berthold Technologies GmbH & Co. KG. (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • GE Healthcare (General Electric Company) (United States)
  • Illumina, Inc. (United States)
  • Innopsys Inc. (United States)
  • Molecular Devices, LLC. (Danaher Corporation) (United States)
  • PerkinElmer, Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • Integrated Gulf Biosystems (Abu Dhabi)
Additional players considered in the study are as follows:
Arrayit (United States) , Bioautomation Corporation (United States) , EUROIMMUN (Germany) , Bio-Rad Laboratories, Inc. (United States) , Molecular Devices (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 221 Pages 78 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Microarray Scanner Quantitative research analysis
Global (United States, European Union and China) Microarray Scanner Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Microarray Scanner Market are by type [Charge-Coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, Fluorescence Microarray Scanners, Microarray Laser Scanners, Microarray Plate Scanners and Others], by end use application [Drug Discovery, Gene Expression, Mutation Detection, SNP analysis and Others].
The Microarray Scanner Market is gaining popularity and expected to see strong valuation by 2030.
  • Increase in the population with infectious diseases such as COVID-19
  • Increasing focus in gene expression and drug discovery to address the different infection spread

Know More About Global (United States, European Union and China) Microarray Scanner Report?

Have a Query? Click Here

Other Related Reports

Breast Pump Comprehensive Study by Type (Manual Breast Pump, Electric Breast Pump, Battery-Operated Breast Pumps, Hands-Free Breast Pump, Double Breast Pump, Others), Application (Drinking, Suckle, O...
$ 3450
Blood Pressure Monitors Comprehensive Study by Type (Aneroid BP Monitors, Digital BP Monitors, Ambulatory BP Monitors, Blood Pressure Instrument Accessories), Technology (Wearable Watches, Smartphone...
$ 3450
Medical Hyperbaric Oxygen Chamber Equipment Comprehensive Study by Type (Hyperbaric Oxygen Chambers, Chamber Accessories, Consumables), Application (Injuries, Infections, Insufficiencies), End User (...
$ 3650
Aggregometer Comprehensive Study by Type (Two-channel aggregometer, Four-channel aggregometer, Six-channel aggregometer, Eight-channel aggregometer, Others), Application (Clinical Diagnosis, Clinical...
$ 3650
Coronary Atherectomy Devices Comprehensive Study by Type (Laser Atherectomy, Orbital Atherectomy, Rotational Atherectomy, Others), Application (Peripheral Vascular, Cardiovascular, Neurovascular), En...
$ 3450
Transcranial Doppler Devices Comprehensive Study by Type (Non-duplex (non-imaging) Transcranial Doppler Device, Duplex (imaging) Transcranial Doppler Device), Application (Subarachnoid hemorrhage (SA...
$ 3750